XML 19 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:        
Net income     $ 12,259 $ 22,922
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization     3,950 4,155
Net amortization of premiums on securities     1,378 1,052
Provision for credit losses $ 3,746 $ 2,354 17,661 3,547
Share-based compensation 369 453 701 635
Deferred income tax expense (benefit)     (1,663) 680
Proceeds from sale of loans held for sale     31,504 15,432
Originations of loans held for sale     (32,899) (14,163)
Income on company owned life insurance (462) (424) (927) (834)
Net gain on sale of loans held for sale (731) (407) (1,035) (589)
Net gain on investment securities (674) (166) (895) (113)
Net gain on other assets 1 (9) (63) (58)
Increase in other assets     (36,571) (2,786)
Increase (decrease) in other liabilities     16,772 (747)
Net cash provided by operating activities     10,172 29,133
Cash flows from investing activities:        
Purchases of available for sale securities     (121,622) (20,932)
Purchases of held to maturity securities     (4,761) (7,494)
Proceeds from principal payments, maturities and calls on available for sale securities     38,706 40,119
Proceeds from principal payments, maturities and calls on held to maturity securities     53,282 54,735
Proceeds from sales of securities available for sale 29,896 39,667 50,153 44,615
Net loan originations     (276,409) (88,993)
Loans sold to others       21,077
Purchases of company owned life insurance, net of proceeds received     (7) (24)
Proceeds from sales of other assets     482 329
Purchases of premises and equipment     (2,375) (1,684)
Net cash (used in) provided by investing activities     (262,551) 41,748
Cash flows from financing activities:        
Net increase in deposits     438,333 105,082
Net decrease in short-term borrowings     (170,200) (161,000)
Purchases of common stock for treasury     (196) (193)
Cash dividends paid to common and preferred shareholders     (8,895) (8,537)
Net cash provided (used in) by financing activities     259,042 (64,648)
Net increase in cash and cash equivalents     6,663 6,233
Cash and cash equivalents, beginning of period     112,947 102,755
Cash and cash equivalents, end of period $ 119,610 $ 108,988 $ 119,610 $ 108,988